Keyword: The Medicines Company
The Medicines Company reported that its PCSK9 drug, inclisiran, cut "bad" LDL cholesterol in patients with plaque buildup in their arteries.
Medicines Company showed its siRNA inclisiran has a clean safety profile and is as effective as incumbent drugs sold by Amgen, Regeneron and Sanofi.
Medicines Company is yet to share the efficacy data that will show whether inclisiran can compete but has sought to tackle lingering safety concerns.
Merck scouts CEO replacements after scrapping retirement rule; Flatiron Health nabs biopharma vet; and ex-Medicines Company exec lands at Scynexis.
Scynexis has nabbed Nkechi Azie as its VP of clinical development from her role as infectious disease head at The Medicines Company.
The Medicines Company announced long-term data for inclisiran, showing that the drug lowered “bad” LDL cholesterol by more than 50%.
Qpex Biopharma launched as a new infectious disease company, simultaneously obtaining $33 million and preclinical assets from The Medicines Company.
PPD unveiled an enrollment model that identifies eligible patients and connects them with study sites before startup, inverting the typical process.
Gilead’s director of oncology clinical research jumps to Compugen, longtime Teva exec becomes Dr. Reddy's COO, Astellas names new ethics & compliance head.
Germano takes up the position 8 months after a shift in focus at Intrexon led him to give up the president post at the synthetic biology company.